- Investopedia•7 days ago
We take a deep dive into the NASDAQ Biotech ETF (IBB) to look for great investment ideas.
- Zacks•15 days ago
ARIAD Pharmaceuticals, Inc. (ARIA) announced the submission of a Marketing Authorisation Application (MAA) for its experimental ALK inhibitor, brigatinib, with the European Medicines Agency (EMA).
- Motley Fool•16 days ago
The drugmaker's stock soared last month on a rich buyout offer from Japan's Takeda Pharmaceutical.
ARIA : Summary for ARIAD Pharmaceuticals, Inc. - Yahoo Finance
ARIAD Pharmaceuticals, Inc. (ARIA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||23.94 - 23.99|
|52 Week Range||4.67 - 23.99|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-137.79|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|